Prospective study of malabsorption and malnutrition after esophageal and gastric cancer surgery

Annals of Surgery

Volumn 262, Issue 5, 2015, Pages 803-808

  Heneghan, Helen M ^a   Zaborowski, Alexandra ^a   Fanning, Michelle ^a   Mchugh, Aisling ^a   Doyle, Suzanne ^a   Moore, Jenny ^a   Ravi, Nayarasamy ^a   Reynolds, John V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

esophageal cancer; esophagectomy; gastrectomy; gastric cancer; malabsorption; malnutrition

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; CYANOCOBALAMIN; ELASTASE; FERRITIN; FOLIC ACID; HEMOGLOBIN; RETINOL; TRACE ELEMENT;

ADULT; ARTICLE; BACTERIAL OVERGROWTH; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CANCER PROGNOSIS; COHORT ANALYSIS; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; ESOPHAGUS RESECTION; FAT FREE MASS; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL SYMPTOM RATING SCALE; HUMAN; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MALNUTRITION; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RETINOL DEFICIENCY; SARCOPENIA; SKELETAL MUSCLE; STOMACH ADENOCARCINOMA; STOMACH CANCER; WEIGHT REDUCTION; ADVERSE EFFECTS; ESOPHAGEAL NEOPLASMS; IRELAND; MALABSORPTION SYNDROMES; POSTOPERATIVE COMPLICATIONS; STOMACH NEOPLASMS; TIME;

ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; INCIDENCE; IRELAND; MALABSORPTION SYNDROMES; MALE; MALNUTRITION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY OF LIFE; STOMACH NEOPLASMS; TIME FACTORS;

EID: 84954312181     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001445     Document Type: Article

References (38)

1. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355: 11-20
2. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-Analysis. Lancet Oncol. 2011; 12: 681-692
3. Reynolds JV, Donohoe CL, McGillycuddy E, et al. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. J Thorac Cardiovasc Surg. 2012; 143: 1130-1137
4. Reynolds JV, Muldoon C, Hollywood D, et al. Long-Term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg. 2007; 245: 707-716
5. Greene CL, DeMeester SR, Worrell SG, et al. Alimentary satisfaction, gastrointestinal symptoms, and quality of life 10 or more years after esophagectomy with gastric pull-up. J Thorac Cardiovasc Surg. 2014; 147: 909-914
6. Jacobs M, Macefield RC, Elbers RG, et al. Meta-Analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery. Qual Life Res. 2014; 23: 1097-1115
7. Djarv T, Lagergren P. Quality of life after esophagectomy for cancer. Expert Rev Gastroenterol Hepatol. 2012; 6: 115-122
8. Djarv T, Lagergren J, Blazeby JM, et al. Long-Term health-related quality of life following surgery for oesophageal cancer. Br J Surg. 2008; 95: 1121-1126
9. Huddy JR, Macharg FM, Lawn AM, et al. Exocrine pancreatic insufficiency following esophagectomy. Dis Esophagus. 2013; 26: 594-597
10. al-Hadrani A, Lavelle-Jones M, Kennedy N, et al. Bile acid malabsorption in patients with post-vagotomy diarrhoea. Ann Chir Gynaecol. 1992; 81: 351-353
11. Paik CN, Choi MG, Lim CH, et al. The role of small intestinal bacterial overgrowth in postgastrectomy patients. Neurogastroenterol Motil. 2011; 23: e191-e196
12. Puleston J, Morgan H, Andreyev J. New treatment for bile salt malabsorption. Gut. 2005; 54: 441-442
13. Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007; 3: 112-122
14. Fukushima H, Yokoyama M, Nakanishi Y, et al. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma. PLoS One. 2015; 10: e0115895
15. Iritani S, Imai K, Takai K, et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol. 2015; 50: 323-332
16. Kulich KR, Madisch A, Pacini F, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008; 6: 12
17. Blackburn GL, Bistrian BR, Maini BS, et al. Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr. 1977; 1: 11-22
18. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med. 1991; 325: 525-532
19. Ryan AM, Reynolds JV, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009; 249: 355-363
20. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008; 9: 629-635
21. Ronellenfitsch U, Schwarzbach M, Hofheinz R, et al. Perioperative chemo(-radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Cochrane Database Syst Rev. 2013; 5: CD008107
22. Oppedijk V, van der Gaast A, van Lanschot JJ, et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014; 32: 385-391
23. van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012; 366: 2074-2084
24. Kim AR, Cho J, Hsu YJ, et al. Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg. 2012; 256: 1008-1013
25. Kiyama T, Mizutani T, Okuda T, et al. Postoperative changes in body composition after gastrectomy. J Gastrointest Surg. 2005; 9: 313-319
26. Ouattara M, D'Journo XB, Loundou A, et al. Body mass index kinetics and risk factors of malnutrition one year after radical oesophagectomy for cancer. Eur J Cardiothorac Surg. 2012; 41: 1088-1093
27. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357: 741-752
28. Martin L, Lagergren J, Lindblad M, et al. Malnutrition after oesophageal cancer surgery in Sweden. Br J Surg. 2007; 94: 1496-1500
29. Martin L, Lagergren P. Long-Term weight change after oesophageal cancer surgery. Br J Surg. 2009; 96: 1308-1314
30. Baba M, Aikou T, Natsugoe S, et al. Appraisal of ten-year survival following esophagectomy for carcinoma of the esophagus with emphasis on quality of life. World J Surg. 1997; 21: 282-285
31. Gemici C, Sargin M, Uygur-Bayramicli O, et al. Risk of endocrine pancreatic insufficiency in patients receiving adjuvant chemoradiation for resected gastric cancer. Radiother Oncol. 2013; 107: 195-199
32. Levy P, Menzelxhiu A, Paillot B, et al. Abdominal radiotherapy is a cause for chronic pancreatitis. Gastroenterology. 1993; 105: 905-909
33. Mantis NJ, Rol N, Corthesy B. Secretory IgA?s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011; 4: 603-611
34. Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008; 28: 293-298
35. Andreyev HJ, Muls AC, Norton C, et al. Guidance: the practical management of the gastrointestinal symptoms of pelvic radiation disease. Frontline Gastroenterol. 2015; 6: 53-72
36. Miyazaki T, Tanaka N, Hirai H, et al. Ghrelin level and body weight loss after esophagectomy for esophageal cancer. J Surg Res. 2012; 176: 74-78
37. Takata A, Takiguchi S, Miyazaki Y, et al. Randomized phase II study of the anti-inflammatory effect of ghrelin during the postoperative period of esophagectomy. Ann Surg. 2015; 262: 230-236
38. Papamargaritis D, Panteliou E, Miras AD, et al. Mechanisms of weight loss, diabetes control and changes in food choices after gastrointestinal surgery. Curr Atheroscler Rep. 2012; 14: 616-623